• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于胰岛自身抗体特征对1型糖尿病风险进行分层。

Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics.

作者信息

Achenbach Peter, Warncke Katharina, Reiter Jürgen, Naserke Heike E, Williams Alistair J K, Bingley Polly J, Bonifacio Ezio, Ziegler Anette-G

机构信息

Diabetes Research Institute and 3rd Medical Department, Hospital München-Schwabing, Munich, Germany.

出版信息

Diabetes. 2004 Feb;53(2):384-92. doi: 10.2337/diabetes.53.2.384.

DOI:10.2337/diabetes.53.2.384
PMID:14747289
Abstract

Family history of type 1 diabetes and autoantibodies to the islet antigens insulin (IAA), glutamate decarboxylase (GADA), and the protein tyrosine phosphatase-like protein IA-2 (IA-2A) are strong predictors of type 1 diabetes, but the rate of progression to diabetes in multiple islet autoantibody-positive relatives varies widely. We asked whether detailed characterization of islet autoantibodies that included determination of titer, epitope specificity, and IgG subclass would improve diabetes prediction in a large cohort of autoantibody-positive relatives. The study shows a strong association between risk and high titer, broad antibody responses to IA-2 and insulin. The highest risks were associated with high-titer IA-2A and IAA, IgG2, IgG3, and/or IgG4 subclass of IA-2A and IAA, and antibodies to the IA-2-related molecule IA-2beta. Using models based on these antibody characteristics, autoantibody-positive relatives can be classified into groups with risks of diabetes ranging from 7 to 89% within 5 years.

摘要

1型糖尿病家族史以及针对胰岛抗原胰岛素(IAA)、谷氨酸脱羧酶(GADA)和蛋白酪氨酸磷酸酶样蛋白IA-2(IA-2A)的自身抗体是1型糖尿病的有力预测指标,但多个胰岛自身抗体阳性亲属发展为糖尿病的速率差异很大。我们询问,对胰岛自身抗体进行详细表征,包括测定滴度、表位特异性和IgG亚类,是否会改善一大群自身抗体阳性亲属的糖尿病预测。该研究显示风险与高滴度、对IA-2和胰岛素的广泛抗体反应之间存在密切关联。最高风险与高滴度IA-2A和IAA、IA-2A和IAA的IgG2、IgG3和/或IgG4亚类以及针对IA-2相关分子IA-2β的抗体有关。使用基于这些抗体特征的模型,自身抗体阳性亲属可被分为5年内糖尿病风险从7%到89%不等的组。

相似文献

1
Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics.基于胰岛自身抗体特征对1型糖尿病风险进行分层。
Diabetes. 2004 Feb;53(2):384-92. doi: 10.2337/diabetes.53.2.384.
2
Combined positivity for HLA DQ2/DQ8 and IA-2 antibodies defines population at high risk of developing type 1 diabetes.HLA DQ2/DQ8和IA-2抗体联合阳性定义了1型糖尿病高风险人群。
Diabetologia. 2005 Apr;48(4):687-94. doi: 10.1007/s00125-005-1702-x. Epub 2005 Mar 9.
3
Natural history of beta-cell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population.从普通人群中招募的对1型糖尿病遗传易感性增加的幼儿β细胞自身免疫的自然病史。
J Clin Endocrinol Metab. 2002 Oct;87(10):4572-9. doi: 10.1210/jc.2002-020018.
4
Two-step islet autoantibody screening for risk assessment of type 1 diabetes in relatives.两步法胰岛自身抗体筛查用于评估1型糖尿病亲属的患病风险
Diabetes Care. 1998 Sep;21(9):1445-50. doi: 10.2337/diacare.21.9.1445.
5
IA-2 autoantibodies predict impending type I diabetes in siblings of patients.IA-2自身抗体可预测糖尿病患者兄弟姐妹中即将发生的I型糖尿病。
Diabetologia. 2002 Dec;45(12):1658-66. doi: 10.1007/s00125-002-0949-8. Epub 2002 Nov 12.
6
A simple screening method for individuals at risk of developing type 1 diabetes: measurement of islet cell autoantibodies (GADA, IA-2A, and IAA) on dried capillary blood spots collected on filter paper.一种用于筛查 1 型糖尿病高危个体的简单方法:在滤纸上采集的干毛细血管血斑上检测胰岛细胞自身抗体(GADA、IA-2A 和 IAA)。
Horm Metab Res. 2012 Oct;44(11):855-60. doi: 10.1055/s-0032-1316349. Epub 2012 Aug 14.
7
High-titer autoantibodies against glutamic acid decarboxylase plus autoantibodies against insulin and IA-2 predicts insulin requirement in adult diabetic patients.高滴度抗谷氨酸脱羧酶自身抗体联合抗胰岛素及抗胰岛细胞抗原2自身抗体可预测成年糖尿病患者的胰岛素需求。
J Autoimmun. 1999 Mar;12(2):131-5. doi: 10.1006/jaut.1998.0261.
8
Autoantibodies associated with Type I diabetes mellitus persist after diagnosis in children.与1型糖尿病相关的自身抗体在儿童确诊后依然存在。
Diabetologia. 1998 Nov;41(11):1293-7. doi: 10.1007/s001250051067.
9
Disease-associated autoantibodies and HLA-DQB1 genotypes in children with newly diagnosed insulin-dependent diabetes mellitus (IDDM). The Childhood Diabetes in Finland Study Group.新诊断的胰岛素依赖型糖尿病(IDDM)患儿的疾病相关自身抗体和HLA - DQB1基因型。芬兰儿童糖尿病研究小组。
Clin Exp Immunol. 1999 Apr;116(1):78-83. doi: 10.1046/j.1365-2249.1999.00863.x.
10
Antibodies to oxidized insulin improve prediction of type 1 diabetes in children with positive standard islet autoantibodies.针对氧化胰岛素的抗体可改善对阳性标准胰岛自身抗体儿童 1 型糖尿病的预测。
Diabetes Metab Res Rev. 2019 May;35(4):e3132. doi: 10.1002/dmrr.3132. Epub 2019 Feb 18.

引用本文的文献

1
Type 1 diabetes risk factors, risk prediction and presymptomatic detection: Evidence and guidance for screening.1型糖尿病的危险因素、风险预测及症状前检测:筛查的证据与指南
Diabetes Obes Metab. 2025 Mar 25. doi: 10.1111/dom.16354.
2
Characterization of Anti-Insulin Antibodies in Type 1 and Type 2 Diabetes Mellitus: Clinical Relevance.1型和2型糖尿病中抗胰岛素抗体的特征:临床相关性
Int J Mol Sci. 2025 Feb 18;26(4):1730. doi: 10.3390/ijms26041730.
3
Time to reframe the disease staging system for type 1 diabetes.重新构建 1 型糖尿病疾病分期系统的时机已到。
Lancet Diabetes Endocrinol. 2024 Dec;12(12):924-933. doi: 10.1016/S2213-8587(24)00239-0.
4
Consensus Guidance for Monitoring Individuals With Islet Autoantibody-Positive Pre-Stage 3 Type 1 Diabetes.胰岛自身抗体阳性的 3 期 1 型糖尿病前期患者监测的共识指导。
Diabetes Care. 2024 Aug 1;47(8):1276-1298. doi: 10.2337/dci24-0042.
5
Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes.胰岛自身抗体阳性的 3 期 1 型糖尿病前阶段患者监测的共识指南。
Diabetologia. 2024 Sep;67(9):1731-1759. doi: 10.1007/s00125-024-06205-5.
6
Advances in risk predictive performance of pre-symptomatic type 1 diabetes via the multiplex Antibody-Detection-by-Agglutination-PCR assay.通过多重抗体检测凝集 PCR 检测方法,实现了无症状 1 型糖尿病风险预测性能的提高。
Front Endocrinol (Lausanne). 2024 Feb 8;15:1340436. doi: 10.3389/fendo.2024.1340436. eCollection 2024.
7
Safety, tolerability and immunogenicity of PRV-101, a multivalent vaccine targeting coxsackie B viruses (CVBs) associated with type 1 diabetes: a double-blind randomised placebo-controlled Phase I trial.PRV-101 是一种针对与 1 型糖尿病相关的柯萨奇 B 病毒 (CVB) 的多价疫苗,其安全性、耐受性和免疫原性:一项双盲随机安慰剂对照的 I 期临床试验。
Diabetologia. 2024 May;67(5):811-821. doi: 10.1007/s00125-024-06092-w. Epub 2024 Feb 19.
8
The immunology of type 1 diabetes.1 型糖尿病的免疫学。
Nat Rev Immunol. 2024 Jun;24(6):435-451. doi: 10.1038/s41577-023-00985-4. Epub 2024 Feb 2.
9
A novel, high-performance, low-volume, rapid luciferase immunoprecipitation system (LIPS) assay to detect autoantibodies to zinc transporter 8.一种新型、高性能、低容量、快速的荧光素酶免疫沉淀系统(LIPS)检测锌转运蛋白 8 自身抗体的方法。
Clin Exp Immunol. 2024 Feb 19;215(3):215-224. doi: 10.1093/cei/uxad139.
10
Resolution of dysglycaemia after treatment of monoclonal gammopathy of endocrine significance.内分泌相关意义单克隆丙种球蛋白血症治疗后血糖异常的缓解。
Eur J Endocrinol. 2023 Dec 6;189(6):K25-K29. doi: 10.1093/ejendo/lvad138.